Stanislas Veillet

USPTO Granted Patents = 9 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 17)

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

4. 2 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

5. 2 out of 2

Institut Biophytis Sas

patents

6. 2 out of 67

Université Pierre Et Marie Curie

patents

7. 1 out of 1

Université Paris 6 Pierre Et Marie Curie

patent

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440500 - Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases (2025-10-14),

2. 12215067 - Chemical compounds targeting the eye and use thereof in the treatment of eye diseases (2025-02-04),

3. 11542295 - Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies (2023-01-03),

4. 10513503 - Use of 3-deoxyanthocyanidins for treating occular diseases (2019-12-24),

5. 10316056 - Chemical compounds and use thereof for improving muscular quality (2019-06-11),

6. 10314804 - Composition containing norbixin for protecting cells of the retinal pigment epithelium (2019-06-11),

7. 9938315 - Chemical compounds and use thereof for improving muscular quality (2018-04-10),

8. 9173823 - Preparation for sun protection (2015-11-03),

9. 8236359 - Use of phytoecdysones in the preparation of a composition for acting on the metabolic syndrome (2012-08-07),

Title: The Innovative Contributions of Stanislas Veillet

Introduction

Stanislas Veillet is a notable inventor based in Savigny sur Orge, France. He has made significant contributions to the field of biomedical research, particularly in the treatment of neuromuscular diseases. With a total of 9 patents to his name, Veillet's work has the potential to impact many lives.

Latest Patents

Among his latest patents, Veillet has developed innovative treatments using phytoecdysones and their derivatives. These compounds are intended for use in treating neuromuscular diseases such as spinal muscular atrophy and amyotrophic lateral sclerosis. His research focuses on addressing specific disorders of motor neurons that lead to muscular function alterations. Additionally, he has disclosed chemical compounds that target the eye, particularly derivatives of norbixin. These compounds are aimed at treating eye diseases, including age-related macular degeneration and Stargardt's disease.

Career Highlights

Veillet has worked with prominent organizations such as Biophytis and Sorbonne Université. His career reflects a commitment to advancing medical science through innovative research and development. His work has garnered attention in the scientific community, showcasing his dedication to improving health outcomes.

Collaborations

Some of his notable coworkers include René Lafont and Jose-Alain Sahel. Their collaborative efforts have contributed to the success of various projects and research initiatives.

Conclusion

Stanislas Veillet's contributions to the field of biomedical research are commendable. His innovative patents and collaborations highlight his commitment to addressing critical health challenges. Through his work, he continues to pave the way for advancements in the treatment of neuromuscular and eye diseases.

This text is generated by artificial intelligence and may not be accurate.